Comparing CSF amyloid‐beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status

Abstract Introduction We evaluated for two novel automated biomarker assays how cerebrospinal fluid (CSF) amyloid beta (Aβ)1– 42‐ratios improved the concordance with amyloid positron emission tomography (PET) positivity compared to Aβ1– 42 alone. Methods We selected 288 individuals from the Amsterda...

詳細記述

書誌詳細

主要な著者:	Eline A. J. Willemse, Betty M. Tijms, Bart N. M. vanBerckel, Nathalie Le Bastard, Wiesje M. van derFlier, Philip Scheltens, Charlotte E. Teunissen
フォーマット:	Artigo
言語:	Inglês
出版事項:	Wiley 2021-01-01
シリーズ:	Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
主題:	Alzheimer's disease amyloid‐beta amyloid positron emission tomography biomarkers cerebrospinal fluid concordance cut‐points
オンライン･アクセス:	https://doi.org/10.1002/dad2.12182
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!